Treatment of Schistosomal Myeloradiculopathy with Praziquantel and Corticosteroids and Evaluation by Magnetic Resonance Imaging: A Longitudinal Study | Zendy

Lilian Cristina Santos Sinfronio da Silva | Zendy; Pedro E. Maciel | Zendy; João Gabriel Ribas | Zendy; Silvio Roberto Souza-Pereira | Zendy; Carlos Antunes | Zendy; José Roberto Lambertucci | Zendy

Open Access

Treatment of Schistosomal Myeloradiculopathy with Praziquantel and Corticosteroids and Evaluation by Magnetic Resonance Imaging: A Longitudinal Study

Author(s) -

Lilian Cristina Santos Sinfronio da Silva,

Pedro E. Maciel,

João Gabriel Ribas,

Silvio Roberto Souza-Pereira,

Carlos Antunes,

José Roberto Lambertucci

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/425611

Subject(s) - medicine , magnetic resonance imaging , surgery , asymptomatic , prednisone , methylprednisolone , radiology , praziquantel , schistosomiasis , immunology , helminths

The best treatment for schistosomal myeloradiculopathy (SMR) remains undefined. There is also no longitudinal study to estimate the value of magnetic resonance imaging (MRI) in the diagnosis and follow-up of this disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research